Searched for
EMCURE PHARMA LISTING PRICE
Vedanta Aluminium, other demerged stocks surge up to 5%. Which has been the best performed since market debut?Vedanta’s newly listed demerged entities outperformed the broader market on Friday, with shares of Vedanta Aluminium Metal, Vedanta Iron an...- Horizon Reclaim shares list at 47% premium over IPO price on BSE SME platformHorizon Reclaim (India) debuted on the BSE SME platform with a 46.6% premium, listing at Rs 151 against its IPO price of Rs 103. The Rs 54....
- NSE IPO: BSE hosts double the listed companies but numbers tell a different storyAs NSE prepares for its massive IPO, its DRHP reveals it significantly outperforms BSE in key trading metrics despite having fewer listed c...
- Vedanta Power shares drop 3%, fall below listing price. What lies ahead?Vedanta Power shares fell over 3% on Thursday, slipping below their listing price after debuting earlier this week following the Vedanta de...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...
- Vedanta Aluminium vs Power vs Oil & Gas vs Iron & Steel: Which stock should you buy?Four Vedanta Group companies debuted on the market, with aluminium, iron & steel, and oil & gas shares tumbling while power stocks rose. An...
- Susan Electricals shares to list today. Check GMP ahead of debutIf the grey market trend holds through listing, the stock could open with gains in that range, continuing the trend of strong debuts seen a...
- API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
- Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...
- Sudip Bandyopadhyay bets on pharma, metals and select cyclicals as geopolitical risks easeEasing West Asia tensions boost global markets, prompting investors to reassess opportunities. Market veteran Sudip Bandyopadhyay favors ph...
- Vedanta Iron & Steel shares list at Rs 22 on BSE as mega demerger concludesVedanta Iron & Steel debuted on the BSE at Rs 22 and NSE at Rs 20 on Monday as part of Vedanta's demerger plan. The company, with operation...
- Vedanta Aluminium lists at Rs 527 on BSE after demerger. Is it the group’s new crown jewel?Vedanta Aluminium Metal shares debuted on Monday at Rs 527 on the BSE. The company's market capitalization reached Rs 2.06 lakh crore. Anal...
- PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...
- 'Time to cherry pick again': Porinju Veliyath says small and midcaps have bottomed & Thomas Cook is his latest buyPorinju Veliyath sees the correction in small and midcap stocks ending. He believes patient investors will find rewards. Thomas Cook India ...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
Load More
